Guardant Health, Inc. (GH)
94.44
-8.66
(-8.40%)
USD |
NASDAQ |
Feb 23, 16:00
94.90
+0.46
(+0.49%)
After-Hours: 19:59
Guardant Health Research and Development Expense (Quarterly) : 98.26M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Illumina, Inc. | 238.00M |
| Natera, Inc. | 173.41M |
| Quest Diagnostics, Inc. | -- |
| GeneDx Holdings Corp. | 19.59M |
| EXACT Sciences Corp. | 191.50M |